Clinical Operations, • 9/22/25 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Previous Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Next Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Reducing Patient Burden in Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
Clinical Operations, • 9/22/25 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Previous Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Next Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Reducing Patient Burden in Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
